Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease (Q35596219)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2004
edit
Language Label Description Also known as
English
Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease
scientific article published on January 2004

    Statements

    Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit